Actively Recruiting
Korean Idiopathic Pulmonary Fibrosis Registry
Led by Seoul National University Hospital · Updated on 2019-11-13
3000
Participants Needed
1
Research Sites
569 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a multicenter prospective registry of IPF patients in South Korea. The Seoul National University Bundang Hospital is the coordination center for the Korean IPF Registry built by a collaboration of the Korean Interstitial Lung Diseases (ILD) Study Group.
CONDITIONS
Official Title
Korean Idiopathic Pulmonary Fibrosis Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- IPF patients diagnosed by multidisciplinary discussion
You will not qualify if you...
- Other interstitial lung diseases except for IPF
- Connective tissue disease-related interstitial lung disease
- Exposure-related interstitial lung disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Seoul National University Bundang Hospital
Seongnam-si, South Korea, 13620
Actively Recruiting
Research Team
J
Jong Sun Park, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here